HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
October 3, 2005
- SSP Aims to Quickly Recover Sales Lost Through Business Transfer
October 3, 2005
- NEW PRODUCTS
October 3, 2005
- OTC Drugs Less Potent in Japan Than in the West: Mr Hishikura of GSK
October 3, 2005
- OPINION
October 3, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 3, 2005
- Committee on Health Insurance to Discuss Revision of Medical Fee System
October 3, 2005
- SURVEY 3 articles
October 3, 2005
- GL Needed to Raise Awareness of Cost-effectiveness: Prof. Endo
October 3, 2005
- Patients Contribute to Better Treatment: Dr Nomura
October 3, 2005
- Flat-sum System for Chronic-stage Care Should Be Introduced at All Facilities: Prof. Ikegami
October 3, 2005
- REGULATORY NEWS IN BRIEF
October 3, 2005
- Nihon Medi-physics' FDGscan to Be Covered by Insurance Programs
October 3, 2005
- Taisho Toyama Aims at \120 Mil. Sales per MR ASAP: Mr Uehara of Taisho
September 26, 2005
- Mr Fujii, New President of QTJ, Introduced by Dr Gillings
September 26, 2005
- Alfresa HD, Meisyo to Merge in April 2006
September 26, 2005
- BUSINESS NEWS IN BRIEF
September 26, 2005
- Greater Disclosure Raises Public's Confidence in Company: Dr Breier of Eli Lilly
September 26, 2005
- JPMA to Revise Guidance on Supply of Control Drugs
September 26, 2005
- JPMA to Advocate Improvements in NDA Review, Clinical Trial Consultation Systems
September 26, 2005
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
